China Biotech 2008 & Database Package
| Publication Date | January 2008 |
|---|---|
| Publisher | General Biologic |
| Product Type | Report |
| Pages | 88 |
| ISBN Number | not applicable |
| Product Code | GBI00003 |
Summary
China Biotech 2008 provides an in depth look at biotechnology R&D in China, industry statistics and indicators, and an authoritative directory of biotechnology companies. This report is essential for understanding China's emerging innovators, identifying potential clients and partners, and staying abreast of developments in this dynamic industry.
This comprehensive directory includes companies applying biotechnology in industrial, agricultural, new drug development, and various bio-services sectors, as well as manufacturers of life science related tools and supplies. Each company listing contains pertinent contact information and also details product lines and services offered.
China Biotech database includes more than 400 of China's biotechnology companies across new drug discovery and development, bio-services, agriculture, and manufacturers of life science related tools and supplies. Information included with the subscription:
- I. Company name in English and Chinese
- II. Contact information
- III. Business scope
- VI. Products and services
- V.Founding date
Content
- I. Overview of Biotechnology R&D in China
- Developments since 2006
- Historical Background
- II. The Government and Biotechnology
- Investment
- Key Branches of Government
- Intellectual Property
- Research and Education
- III. Commercial Enterprise
- Multinational Enterprises
- Access to Capital
- New Drug Research and Development
- Biologics
- Agricultural
- Industrial
- Bio-services
- Lab Tools and Supplies
- IV. China's Future in Biotechnology
- V. Sources and Suggested Reading
- VI. Biotechnology Database
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















